Quintrio
Home

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Milestone Scientific, Inc. Common Stock

MLSS

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Last trade $0.2766
Day change -$0.0174 (-5.94%)
Day range $0.278 – $0.307
Volume 123,205
Market cap $27M

Open XASE

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$26.28M
Price / earnings
—
Price / book
7.57×
Price / sales
2.79×
EV / sales
2.62×
EV / EBITDA
-6.14×

Profitability

Earnings per share
-$0.05
Return on assets
-49.64%
Return on equity
-119.38%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.15×
Current ratio
1.85×
Quick ratio
1.14×
Cash ratio
0.47×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$657.76K

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for MLSS, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$2.84M$2.16M$2.06M$2.36M$2.32M$2.23M$2.01M$2.51M
Cost of revenue$930.87K$598.01K$556.31K$719.25K$705.86K$584.99K$502.45K$677.59K
Gross profit$1.91M$1.56M$1.5M$1.64M$1.62M$1.65M$1.51M$1.84M
Selling, general and administrative$2.95M$2.37M$2.55M$2.74M$3.03M$3.26M$3.33M$3.06M
Research and development$6.61K$0$12.33K$16.23K$51.79K$369.12K$217.53K$232.06K
Total operating expenses$2.97M$2.39M$2.58M$2.78M$3.1M$3.65M$3.55M$3.31M
Operating income-$1.06M-$828.08K-$1.08M-$1.13M-$1.48M-$2M-$2.04M-$1.47M
Interest expense$2.23K-$11.77K$0$0$1.52K$3.27K$0$0
Income before taxes-$1.06M-$839.85K-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M-$1.46M
Income taxes$0$0$0$0$0$0$0$0
Net income-$1.06M-$839.85K-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M-$1.46M
Net income attributable to common shareholders-$1.06M-$839.85K-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M-$1.46M
EBITDA-$1.04M-$808.63K-$1.06M-$1.11M-$1.47M-$1.98M-$2.03M-$1.46M
Basic earnings per share-$0.01-$0.01-$0.01-$0.01-$0.02-$0.02-$0.03-$0.02
Diluted earnings per share-$0.01-$0.01-$0.01-$0.01-$0.02-$0.02-$0.03-$0.02

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon

Milestone Scientific announced the commercial rollout of its CompuFlo® Epidural System at Advanced Spine and Pain Management, following a successful pilot program. The company also reported increasing adoption of the system after a Medicare price assignment, highlighting its clinical and economic benefits.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jan 14, 20041-for-3reverse split